These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35771179)

  • 21. [The Importance of MITF Signaling Pathway in the Regulation of Proliferation and Invasiveness of Malignant Melanoma].
    Urban P; Rabajdová M; Veliká B; Špaková I; Bolerázska B; Mareková M
    Klin Onkol; 2016; 29(5):347-350. PubMed ID: 27739313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.
    Keenen B; Qi H; Saladi SV; Yeung M; de la Serna IL
    Oncogene; 2010 Jan; 29(1):81-92. PubMed ID: 19784067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory and functional connection of microphthalmia-associated transcription factor and anti-metastatic pigment epithelium derived factor in melanoma.
    Fernández-Barral A; Orgaz JL; Baquero P; Ali Z; Moreno A; Tiana M; Gómez V; Riveiro-Falkenbach E; Cañadas C; Zazo S; Bertolotto C; Davidson I; Rodríguez-Peralto JL; Palmero I; Rojo F; Jensen LD; del Peso L; Jiménez B
    Neoplasia; 2014 Jun; 16(6):529-42. PubMed ID: 25030625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment.
    Riesenberg S; Groetchen A; Siddaway R; Bald T; Reinhardt J; Smorra D; Kohlmeyer J; Renn M; Phung B; Aymans P; Schmidt T; Hornung V; Davidson I; Goding CR; Jönsson G; Landsberg J; Tüting T; Hölzel M
    Nat Commun; 2015 Nov; 6():8755. PubMed ID: 26530832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In melanoma, beta-catenin is a suppressor of invasion.
    Arozarena I; Bischof H; Gilby D; Belloni B; Dummer R; Wellbrock C
    Oncogene; 2011 Nov; 30(45):4531-43. PubMed ID: 21577209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MITF, the Janus transcription factor of melanoma.
    Koludrovic D; Davidson I
    Future Oncol; 2013 Feb; 9(2):235-44. PubMed ID: 23414473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
    Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.
    Carreira S; Goodall J; Denat L; Rodriguez M; Nuciforo P; Hoek KS; Testori A; Larue L; Goding CR
    Genes Dev; 2006 Dec; 20(24):3426-39. PubMed ID: 17182868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BPTF transduces MITF-driven prosurvival signals in melanoma cells.
    Dar AA; Majid S; Bezrookove V; Phan B; Ursu S; Nosrati M; De Semir D; Sagebiel RW; Miller JR; Debs R; Cleaver JE; Kashani-Sabet M
    Proc Natl Acad Sci U S A; 2016 May; 113(22):6254-8. PubMed ID: 27185926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.
    Giuliano S; Cheli Y; Ohanna M; Bonet C; Beuret L; Bille K; Loubat A; Hofman V; Hofman P; Ponzio G; Bahadoran P; Ballotti R; Bertolotto C
    Cancer Res; 2010 May; 70(9):3813-22. PubMed ID: 20388797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
    Ballotti R; Cheli Y; Bertolotto C
    Mol Cancer; 2020 Dec; 19(1):170. PubMed ID: 33276788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting Lineage-specific MITF Pathway in Human Melanoma Cell Lines by A-485, the Selective Small-molecule Inhibitor of p300/CBP.
    Wang R; He Y; Robinson V; Yang Z; Hessler P; Lasko LM; Lu X; Bhathena A; Lai A; Uziel T; Lam LT
    Mol Cancer Ther; 2018 Dec; 17(12):2543-2550. PubMed ID: 30266801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human melanoma cell growth by the dietary flavonoid fisetin is associated with disruption of Wnt/β-catenin signaling and decreased Mitf levels.
    Syed DN; Afaq F; Maddodi N; Johnson JJ; Sarfaraz S; Ahmad A; Setaluri V; Mukhtar H
    J Invest Dermatol; 2011 Jun; 131(6):1291-9. PubMed ID: 21346776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Wnt/β-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF.
    Wang H; Zhang H; Chen Y; Wang H; Tian Y; Yi X; Shi Q; Zhao T; Zhang B; Gao T; Guo S; Li C; Guo W
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor.
    Widlund HR; Horstmann MA; Price ER; Cui J; Lessnick SL; Wu M; He X; Fisher DE
    J Cell Biol; 2002 Sep; 158(6):1079-87. PubMed ID: 12235125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF.
    Peres J; Damerell V; Chauhan J; Popovic A; Desprez PY; Galibert MD; Goding CR; Prince S
    J Invest Dermatol; 2021 Sep; 141(9):2250-2260.e2. PubMed ID: 33744299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cycloartane triterpenoid (23R, 24E)-23-acetoxymangiferonic acid inhibited proliferation and migration in B16-F10 melanoma via MITF downregulation caused by inhibition of both β-catenin and c-Raf-MEK1-ERK signaling axis.
    Kaneda T; Matsumoto M; Sotozono Y; Fukami S; Nugroho AE; Hirasawa Y; Hamid A HA; Morita H
    J Nat Med; 2019 Jan; 73(1):47-58. PubMed ID: 30084054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MITF and BRN2 contribute to metastatic growth after dissemination of melanoma.
    Simmons JL; Pierce CJ; Al-Ejeh F; Boyle GM
    Sci Rep; 2017 Sep; 7(1):10909. PubMed ID: 28883623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MITF controls the TCA cycle to modulate the melanoma hypoxia response.
    Louphrasitthiphol P; Ledaki I; Chauhan J; Falletta P; Siddaway R; Buffa FM; Mole DR; Soga T; Goding CR
    Pigment Cell Melanoma Res; 2019 Nov; 32(6):792-808. PubMed ID: 31207090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-catenin controls differentiation of the retinal pigment epithelium in the mouse optic cup by regulating Mitf and Otx2 expression.
    Westenskow P; Piccolo S; Fuhrmann S
    Development; 2009 Aug; 136(15):2505-10. PubMed ID: 19553286
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.